Experiences and perceptions of patients with 100% adherence to highly active antiretroviral therapy: A qualitative study

AIDS Patient Care and STDs

Volumn 21, Issue 7, 2007, Pages 509-520

  Sidat, Mohsin ^a   Fairley, Christopher ^a   Grierson, Jeffrey ^b  

^a MELBOURNE SEXUAL HEALTH CENTRE   (Australia)

^b LA TROBE UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; ZIDOVUDINE;

ADULT; AIDS PATIENT; ARTICLE; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; COPING BEHAVIOR; DIARRHEA; DOCTOR PATIENT RELATION; FEMALE; HEALTH PRACTITIONER; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIPODYSTROPHY; MALE; METABOLIC DISORDER; MONOTHERAPY; NAUSEA; PATIENT CARE; PATIENT COMPLIANCE; PERCEPTION; QUALITATIVE RESEARCH; VIRUS LOAD; VOMITING;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; HIV INFECTIONS; HUMANS; INTERVIEWS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PERCEPTION; PHYSICIAN-PATIENT RELATIONS; REPRODUCIBILITY OF RESULTS;

EID: 34547679922     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/apc.2006.0201     Document Type: Article

References (59)

1. Paterson DL, Potoski B, Capitano B. Measurement of adherence to antiretroviral medications. J Acquir Immune Defic Syndr 2002;31:S103-S106.
2. Palella FJ, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998;338:853-860.
3. Murphy EL, Collier AC, Kalish LA, et al. Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease. Ann Intern Med 2001;135:17-26.
4. Siegel K and Lekas H-M. AIDS as a chronic illness: Psychosocial implications. AIDS 2002;16:S69-S76.
5. Singh N, Squier C, Sivek C, Wagener M, Nguyen MH, Yu VL. Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: Prospective assessment with implications for enhancing compliance. AIDS Care 1996;8:261-269.
6. Wright MT. The old problem of adherence: Research on treatment adherence and its relevance for HIV/AIDS. AIDS Care 2000;12:703-710.
7. Read T, Mijch A, Fairley CK. Adherence to antiretroviral therapy: Are we doing enough? Intern Med J 2003;33:254-256.
8. Chesney M. Adherence to HAART Regimens. AIDS Patient Care STDs 2003;17:169-177.
9. Wainberg M, Cameron D. HIV resistance to antiviral drugs: Public health implications. Drug Resist Update 1998;1:104-108.
10. Vermeire E, Hearnshaw H, Van Royen P, Denekens J. Patient adherence to treatment. Three decades of research: A comprehensive review. J Clin Pharm Ther 2001;26:331-342.
11. Chesney MA. Factors affecting adherence to antiretroviral therapy. Clin Infect Dis 2000;30:S171-176.
12. Wilson KJ, Doxanakis A, Fairley CK. Predictors for non-adherence to antiretroviral therapy. Sex Health 2004;1:251-257.
13. Ickovics JR, Meade CS. Adherence to antiretroviral therapy among patients with HIV: A critical link between behavioral and biomedical sciences. J Acquir Immune Defic Syndr 2002;31:S98-S102.
14. Laws MB, Wilson IB, Bowser DM, Kerr SE. Taking antiretroviral therapy for HIV infection: Learning from patients' stories. J Gen Intern Med 2000;15:848-858.
15. Wertz FJ. Phenomenological research methods for counselling psychology. J Couns Psychol 2005;52:167-177.
16. Giorgi A. The phenomenological movement and research in the human sciences. Nurs Sci Q 2005;18:75-82.
17. Sadala MLA, Adorno RCF. Phenomenology as a method to investigate the experience lived: A perspective from Husserl and Merleau Ponty's thought. J Adv Nurs 2002;37:282-293.
18. Moustakas CE. Phenomenological Research Methods. Thousand Oaks, CA: Sage Publications Inc, 1994.
19. Giorgi A. Sketch of a psychological phenomenological method in Phenomenology and psychological research. In: Giorgi A, ed. Phenomenology and Psychological Research. Pittsburgh, PA: Duquesne University Press, 1985:8-22.
20. Malcolm SE, Ng JJ, Rosen RK, Stone VE. An examination of HIV/AIDS patients who have excellent adherence to HAART. AIDS Care 2003;15:251-261.
21. Lewis M, Colbert A, Erlen J, Meyers M. A qualitative study of persons who are 100% adherent to antiretroviral therapy. AIDS Care 2006;18:140-148.
22. Lutfey KE, Wishner WJ. Beyond "Compliance" is "adherence": Improving the prospect of diabetes care. Diabetes Care 1999;22:635-639.
23. Pound P, Britten N, Morgan M, Yardley L, Pope C, Daker-White G, Campbell R. Resisting medicines: A synthesis of qualitative studies of medicine taking. Soc Sci Med 2005;61:133-155.
24. Alfonso V, Geller J, Bermbach N, Drummond A, Montaner JSG. Becoming a "treatment success": What helps and what hinders patients from achieving and sustaining undetectable viral loads. AIDS Patient Care STDs 2006;20:326-334.
25. Johnson MO, Gamarel KE, Rose CD. Changing HIV treatment expectancies: A pilot study. AIDS Care 2006;18:550-553.
26. Kremer H, Ironson G, Schneiderman N, Hautzinger M. To take or not to take: Decision-making about antiretroviral treatment in people living with HIV/AIDS. AIDS Patient Care STDs 2006;20:335-349.
27. Remien RH, Hirky AE, Johnson MO, Weinhardt LS, Whittier D, Minh Le G. Adherence to medication treatment: A qualitative study of facilitators and barriers among a diverse sample of HIV+ men and women in four U.S. cities. AIDS Behav 2003;7:61-72.
28. Erlen JA, Mellors MP. Adherence to combination therapy in persons living with HIV: Balancing the hardships and the blessings. J Assoc Nurses AIDS Care 1999;10:75-84.
29. Gellaitry G, Cooper V, Davis C, Fisher M, Leake H, Horne R. Patients' perceptions of information about HAART: Impact on treatment decisions. AIDS Care 2005;17:367-376.
30. Meredith KL, Jeffe DB, Mundy LM, and Fraser VJ. Sources influencing patients in their HIV medication decisions. Health Educ Behav 2001;28:40-50.
31. Cooper V, Buick D, Horne R, Lambert N, Gellaitry G, Leake H, and Fisher M. Perceptions of HAART among gay men who declined a treatment offer: Preliminary results from an interview-based study. AIDS Care 2002;14:319-328.
32. Horne R, Buick D, Fisher M, Leake H, Cooper V, Weinman J. Doubts about necessity and concerns about adverse effects: Identifying the types of beliefs that are associated with non-adherence to HAART. Int J STD AIDS 2004;15:38-44.
33. Gold RS and Ridge DT. "I will start treatment when I think the time is right": HIV-positive gay men talk about their decision not to access antiretroviral therapy. AIDS Care 2001;13:693-708.
34. Enriquez M, Gore PA, O'Connor MC, McKinsey DS. Assessment of readiness for adherence by HIV-positive males who had previously failed treatment. J Assoc Nurses AIDS Care 2004;15:42-49.
35. Enriquez M, Lackey NR, O'Connor MC, McKinsey DS. Successful adherence after multiple HIV treatment failures. J Adv Nurs 2004;45:438-446.
36. Maisels L, Steinberg J, Tobias C. An Investigation of Why Eligible Patients Do Not Receive HAART. AIDS Patient Care STDs 2001;15:185-191.
37. Wagner G, Iguchi M, Schneider S, Scott J, Anderson D. Placebo practice trials: A tool to assess and improve adherence readiness. HIV Clin Trials 2002;3:475-481.
38. Gebrekristos HT, Mlisana KP, Karim QA. Patients' readiness to start highly active antiretroviral treatment for HIV. BMJ 2005;331:772-775.
39. Highstein GR, Willey C, and Mundy LM. Development of stage of readiness and decisional balance instruments: Tools to enhance clinical decision-making for adherence to antiretroviral therapy. AIDS Behav 2006;10:563-573.
40. Morgenstern TT, Grimes DE, Grimes RM. Assessment of readiness to initiate antiretroviral therapy. HIV Clin Trials 2002;3:168-172.
41. Gao X, Nau DP, Rosenbluth SA, Scott V, Woodward C. The relationship of disease severity, health beliefs and medication adherence among HIV patients. AIDS Care 2000;12:387-398.
42. Mannheimer SB, Matts J, Telzak E, et al. Quality of life in HIV-infected individuals receiving antiretroviral therapy is related to adherence. AIDS Care 2005;17:10-22.
43. Kalichman SC, Difonzo K, Austin J, Webster L, Rompa D. Prospective study of emotional reactions to changes in HIV viral load. AIDS Patient Care STDs 2002;16:113-120.
44. Mugavero M, Ostermann J, Whetten K, et al. Barriers to antiretroviral adherence: The importance of depression, abuse, and other traumatic events. AIDS Patient Care STDs 2006;20:418-428.
45. Golin C, Isasi F, Bontempi JB, Eng E. Secret pills: HIV-positive patients' experiences taking antiretroviral therapy in North Carolina. AIDS Educ Prev 2002;14:318-329.
46. Ostrop NJ, Gill MJ. Antiretroviral medication adherence and persistence with respect to adherence tool usage. AIDS Patient Care STDs 2000;14:351-358.
47. Roberts KJ. Barriers to and facilitators of HIV-positive patients' adherence to antiretroviral treatment regimens. AIDS Patient Care STDs 2000;14:155-168.
48. Wagner GJ, Ryan GW. Relationship between routinization of daily behaviors and medication adherence in HIV-positive drug users. AIDS Patient Care STDs 2004;18:385-393.
49. Roberts KJ. Physician-patient relationships, patient satisfaction, and antiretroviral medication adherence among HIV-infected adults attending a public health clinic. AIDS Patient Care STDs 2002;16:43-50.
50. Schneider J, Kaplan SH, Greenfield S, Li W, Wilson IB. Better physician-patient relationships are associated with higher reported adherence to antiretroviral therapy in patients with HIV infection. J Gen Intern Med 2004;19:1096-1103.
51. Russell J, Krantz S, and Neville S. The patient-provider relationship and adherence to highly active antiretroviral therapy. J Assoc Nurses AIDS Care 2004;15:40-47.
52. Ingersoll KS, Heackman CJ. Patient-clinician relationships and treatment system effects on HIV medication adherence. AIDS Behav 2005;9:89-101.
53. Dibben MR, Lean MEJ. Achieving compliance in chronic illness management: Illustrations of trust relationships between physicians and nutrition clinic patients. Health Risk Soc 2003;5:241-258.
54. Marelich WD, Roberts KJ, Murphy DA, Callari T. HIV/AIDS patient involvement in antiretroviral treatment decisions. AIDS Care 2002;14:17-26.
55. Kumarasamy N, Safren SA, Raminani SR, et al. Barriers and facilitators to antiretroviral medication adherence among patients with HIV in Chennai, India: A qualitative study. AIDS Patient Care STDs 2005;19:526-537.
56. Martini M, D'Elia S, Paoletti F, et al. Adherence to HIV treatment: Results from a 1-year follow-up study. HIV Med 2002;3:62-64.
57. Godin G, Côté JK, Naccache H, Lambert LD, Trottier S. Prediction of adherence to antiretroviral therapy: A one-year longitudinal study. AIDS Care 2005;17:493-504.
58. Tesoriero J, French T, Weiss L, Waters M, Finkelstein R, Agins B. Stability of adherence to highly active antiretroviral therapy over time among clients enrolled in the Treatment Adherence Demonstration Project. J Acquir Immune Defic Syndr 2003;33:484-493.
59. Harman JJ, Amico KR, Johnson BT. Standard of care: Promoting antiretroviral adherence in clinical care. AIDS Care 2005;17:237-251.